LLY

1,075.18

+0.27%↑

JNJ

207.23

+0.6%↑

ABBV

227.72

+0.26%↑

UNH

325.11

-0.71%↓

AZN

91.53

+0.2%↑

LLY

1,075.18

+0.27%↑

JNJ

207.23

+0.6%↑

ABBV

227.72

+0.26%↑

UNH

325.11

-0.71%↓

AZN

91.53

+0.2%↑

LLY

1,075.18

+0.27%↑

JNJ

207.23

+0.6%↑

ABBV

227.72

+0.26%↑

UNH

325.11

-0.71%↓

AZN

91.53

+0.2%↑

LLY

1,075.18

+0.27%↑

JNJ

207.23

+0.6%↑

ABBV

227.72

+0.26%↑

UNH

325.11

-0.71%↓

AZN

91.53

+0.2%↑

LLY

1,075.18

+0.27%↑

JNJ

207.23

+0.6%↑

ABBV

227.72

+0.26%↑

UNH

325.11

-0.71%↓

AZN

91.53

+0.2%↑

Home・Akciju saraksts・Talphera Inc.

Talphera Inc.

Slēgts

1.08 0.93

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

1.01

Max

1.08

Galvenie mērījumi
By Trading Economics
Darbinieki	13

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt
Prognoze 12 mēnešiem	+195.45% upside

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-15M 46M
Iepriekšējā atvēršanas cena	0.15
Iepriekšējā slēgšanas cena	1.08

Talphera Inc. Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 22. dec. 23:54 UTC

Galvenie tirgus virzītāji

Novo Nordisk ADRs Gain on FDA Approval of First GLP-1 in Pill Form

2025. g. 22. dec. 19:08 UTC

Iegādes, apvienošanās, pārņemšana

Correction to Alphabet to Buy Intersect Article

2025. g. 22. dec. 17:21 UTC

Iegādes, apvienošanās, pārņemšana

Alphabet to Buy Intersect for $4.75 Billion as AI-Investment Plans Grow -- Update

2025. g. 22. dec. 16:46 UTC

Iegādes, apvienošanās, pārņemšana

Alphabet to Buy Intersect for $4.75 Billion in Cash

2025. g. 22. dec. 23:50 UTC

Tirgus saruna

Nikkei May Decline as Yen Rebounds -- Market Talk

2025. g. 22. dec. 23:42 UTC

Tirgus saruna

Gold Hits Record High Amid Rising Geopolitical Risks -- Market Talk

2025. g. 22. dec. 22:31 UTC

Peļņas

Zhejiang Sanhua Intelligent Controls: Higher Demand for Air-Conditioning Components Supported Results >002050.SZ

2025. g. 22. dec. 22:31 UTC

Peļņas

Zhejiang Sanhua Intelligent Controls: Higher Demand for Refrigeration Supported Results >002050.SZ

2025. g. 22. dec. 22:30 UTC

Peļņas

Zhejiang Sanhua Intelligent Controls Sees 2025 Net CNY3.87B, Up 25% on Year >002050.SZ

2025. g. 22. dec. 21:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2025. g. 22. dec. 21:50 UTC

Tirgus saruna

Health Care Roundup: Market Talk

2025. g. 22. dec. 21:37 UTC

Iegādes, apvienošanās, pārņemšana

Capricorn: Project Is Contiguous to Capricorn's Golden Range, Fields Find Tenure

2025. g. 22. dec. 21:36 UTC

Iegādes, apvienošanās, pārņemšana

Capricorn to Pay A$500,000 Cash, A$4M in New Shares

2025. g. 22. dec. 21:35 UTC

Iegādes, apvienošanās, pārņemšana

Capricorn to Acquire Prospective Package From Tempest Minerals

2025. g. 22. dec. 21:35 UTC

Iegādes, apvienošanās, pārņemšana

Capricorn Metals to Buy Yalgoo Project Tenement Package for A$4.5M

2025. g. 22. dec. 20:54 UTC

Iegādes, apvienošanās, pārņemšana

Middle West Partners Buys Paul Stuart From Mitsui & Co.

2025. g. 22. dec. 20:52 UTC

Iegādes, apvienošanās, pārņemšana

HCL Technologies: HCLSoftware to Acquire Jaspersoft From Cloud Software Group >532281.BY

2025. g. 22. dec. 20:09 UTC

Tirgus saruna

U.S. Natural Gas Settles Lower in Choppy Trade -- Market Talk

2025. g. 22. dec. 19:56 UTC

Tirgus saruna

Crude Gains as U.S. Increases Actions Against Venezuela -- Market Talk

2025. g. 22. dec. 19:49 UTC

Iegādes, apvienošanās, pārņemšana

A Topsy-Turvy Year for Oracle and the Ellisons Will Bleed into 2026 -- Barrons.com

2025. g. 22. dec. 19:23 UTC

Tirgus saruna

Mexico's Inflation Seen Easing in Early December -- Market Talk

2025. g. 22. dec. 19:23 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 22. dec. 19:02 UTC

Tirgus saruna

Global Energy Roundup: Market Talk

2025. g. 22. dec. 19:02 UTC

Tirgus saruna

Precious Metals Climb to New Heights -- Market Talk

2025. g. 22. dec. 18:45 UTC

Tirgus saruna

Canadian Trade-Exposed Industries At Forefront of Job Weakness -- Market Talk

2025. g. 22. dec. 18:30 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Intersect Selling Portion of Assets as Part of Alphabet Deal -- Market Talk

2025. g. 22. dec. 18:23 UTC

Iegādes, apvienošanās, pārņemšana

What Yogi Berra Would Say About the Talks to Take Over Warner Bros. Discovery -- Barrons.com

2025. g. 22. dec. 17:20 UTC

Tirgus saruna

Health Care Roundup: Market Talk

2025. g. 22. dec. 17:15 UTC

Tirgus saruna

Global Commodities Roundup: Market Talk

2025. g. 22. dec. 17:06 UTC

Iegādes, apvienošanās, pārņemšana

Alphabet to Buy Intersect for $4.75B as AI-Investment Plans Grow -- Update

Salīdzinājums

Cenas izmaiņa

Talphera Inc. Prognoze

Cenas mērķis

By TipRanks

195.45% augšup

Prognoze 12 mēnešiem

Vidējais 3.25 USD 195.45%

Augstākais 3.5 USD

Zemākais 3 USD

Pamatojoties uz 2 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Talphera Inc. — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

2 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 2 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Talphera Inc. — pēdējo 3 mēnešu laikā.

Finanšu rādītāji

Par Talphera Inc.

Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is headquartered in San Mateo, California.